TNF-related apoptosis-inducing ligand (TRAIL) induces apoptosis in Fas ligand-resistant melanoma cells and mediates CD4 T cell killing of target cells

Journal of Immunology

Volumn 161, Issue 5, 1998, Pages 2195-2200

  Thomas, Wayne D ^a   Hersey, Peter ^a  

^a JOHN HUNTER HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CYCLOHEXIMIDE; DACTINOMYCIN; FAS LIGAND; GLYCOPROTEIN GP 39; LIGAND; MONOCLONAL ANTIBODY; RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DAUDI CELL; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MELANOMA CELL; PRIORITY JOURNAL; TARGET CELL DESTRUCTION;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD95; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE, TRANSFORMED; CYTOTOXICITY TESTS, IMMUNOLOGIC; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; IMMUNOSUPPRESSIVE AGENTS; JURKAT CELLS; LIGANDS; MELANOMA; MEMBRANE GLYCOPROTEINS; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032169208     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Gruss, H.-J. 1996. Molecular, structural, and biological characteristics of the tumor necrosis factor ligand superfamily. Int. J. Clin. Lab. Res. 26:143.
2. Chicheportiche, Y., P.R. Bourdon, H Xu, Y.-M. Hsu, H. Scott, C. Hession, I. Garcia, and J. L. Browning. 1997. TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J. Biol. Chem. 272:32401.
3. Nagata, S. 1997. Apoptosis by death factor. Cell 88:355.
4. Wiley, S. R., K. Schooley, P. J. Smolak, W. S. Din, C.-P. Huang, J. K. Nicholl, G. R. Sutherland, T. D. Smith, C. Rauch, C. A. Smith, and R. G. Goodwin. 1995. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3:673.
5. Pitti, R. M., S. A. Marsters, S. Ruppert, C. J. Donahue, A. Moore, and A. Ashkenazi. 1996. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J. Biol. Chem. 271:12687.
6. Mariani, S. M., B. Matiba, E. A. Armandola, and P. H. Krammer. 1997. Interleukin 1β-converting enzyme related proteases/caspases are involved in TRAIL-induced apoptosis of myeloma and leukemia cells. J. Cell Biol. 137:221.
7. Snell, V., K. Clodi, S. Zhao, R. Goodwin, E. K. Thomas, S. W. Morris, M. E. Kradin, F. Cabanillas, M. Andreeff, and A. Younes. 1997. Activity of TNF-related apoptosis-inducing ligand (TRAIL) in haematological malignancies. Br. J. Haematol. 99:618.
8. Pan, G., K. O'Rourke, A. M. Chinnaiyan, R. Gentz, R. Ebner, J. Ni, and V. M. Dixit. 1997. The receptor for the cytotoxic ligand TRAIL. Science 276:111.
9. Walczak, H., M. A. Degli-Esposti, R. S. Johnson, P. J. Smolak, J. Y. Waugh, N. Boiani, M. S. Timour, M. J. Gerhart, K. A. Schooley, C. A. Smith, R. G. Goodwin, and C. T. Rauch. 1997. TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL. EMBO J. 16:5386.
10. Degli-Esposti, M. A., P. J. Smolak, H. Walczak, J. Waugh, C.-P. Huang, R. F. DuBose, R. G. Goodwin, and C. A. Smith. 1997. Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family. J. Exp. Med. 186:1165.
11. Sheridan, J. P., S. A. Marsters, R. M. Pitti, A. Gurny, M. Skubatch, D. Baldwin, L. Ramakrishnan, C. L. Gray, K. Baker, W. I. Wood, A. D. Goddard, P. Godowski, and A. Ashkenazi. 1997. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 277:818.
12. Gura, T. 1997. How TRAIL kills cancer cells, but not normal cells. Cancer Res. 277:768.
13. Pan, G., J. Ni, Y.-F. Wei, G. Yu, R. Gentz, and V. M. Dixit. 1997. An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 277:815.
14. + T cell-mediated cytotoxicity. J. Immunol. 152:1127.
15. Thomas, W. D., and P. Hersey. 1998. CD4 T cells kill melanoma cells by mechanisms that are independent of Fas (CD95). Int. J. Cancer 75:1.
16. Chen, Q., M. Smith, T. Nguyen, D. W. Maher, and P. Hersey. 1994. T cell recognition of melanoma antigens in association with HLA-A1 on allogeneic melanoma cells. Cancer Immunol. Immunother. 34:385.
17. Alderson, M. R., T. W. Tough, T. Davis-Smith, S. Braddy, B. Falk, K. A. Schooley, R. G. Goodwin, C. A. Smith, F. Ramsdell, and D. H. Lynch. 1995. Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 181:71.
18. Nicoletti, I., G. Migliorati, M. C. Pagliacci, F. Grignani, and C. Riccardi. 1991. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 139:271.
19. Tanaka, M., T. Itai, M. Adachi, and S. Nagata. 1998. Downregulation of Fas ligand by shedding. Nat. Med. 4:31.
20. Thome, M., P. Schneider, K. Hofmann, H. Fickenscher, E. Meinl, F. Neipel, C. Mattmann, K. Burns, J. L. Bodmer, M. Schroter, C. Scaffidi, P. H. Krammer, M. E. Peter, and J. Tschopp. 1997. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 386:517.
21. Irmler, M., M. Thome, M. Hahne, P. Schneider, K. Hofmann, V. Steiner, J.-L. Bodmer, M. Schroter, K. Burns, C. Mattmann, D. Rimoldi, L. E. French, and J. Tschopp. 1997. Inhibition of death receptor signals by cellular FLIP. Nature 388:190.
22. + T cell clones involve multiple effector mechanisms. Cell. Immunol. 147:188.
23. + cytotoxic T lymphocytes. Hum. Immunol. 45:64.
24. Hersey, P., E. Murray, J. Grace, and W. H. McCarthy. 1985. Current research on immunopathology of melanoma: analysis of lymphocyte populations in relation to antigen expression and histological features of melanoma. Pathology 17:385.
25. Tefany, F. J., R. S. Barnetson, G. M. Halliday, S. W. McCarthy, and W.H. McCarthy. 1991. Immunocytochemical analysis of the cellular infiltrate in primary regressing and non-regressing malignant melanoma. J. Invest. Dermatol. 97:197.
26. Thomas, W. D., M. J. Smith, Z. Si, and P. Hersey. 1996. Expression of the co-stimulatory molecule CD40 on melanoma cells. Int. J. Cancer 68:795.